Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 09-07-2020 | Practice Area: | Corporate and M&A |
| Deal Title: | JW Therapeutics Completion of Series B Round Financing | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
JW Therapeutics announced the completion of a USD100 million Series B round financing. The investment was co-led by CPE and Mirae Asset, jointed by CR-CP Life Science Fund and Oriza Holdings, as well as existing investors including Loyal Valley Capital, Temasek, Sequoia Capital China, ARCH Venture Partners, Juno Therapeutics, a Bristol Myers Squibb company, and WuXi AppTec. This round of financing brought the total capital raised to over USD200 million.
Latham and Watkins LLP represented Juno Therapeutics in the transaction.
|
||
| Financial Center: | Silicon Valley | Value: | 0.00-100.00 |
| Advised Party: | Venture/Growth Investor | Law Firm | Latham & Watkins |
| Investee 1 Jurisdiction | United States | Investee 2 Jurisdiction | United States |
| Classification: |
Venture and Growth Capital Healthcare |
Lawyer | Judith A Hasko |
